Seltorexant
id:
seltorexant-291-17045133
title:
Seltorexant
text:
Seltorexant, also known by its developmental code names MIN-202 and JNJ-42847922, is an orexin antagonist medication which is under development for the treatment of depression and insomnia. It is a selective antagonist of the orexin OX2 receptor (2-SORA). The medication is taken by mouth. As of February 2022, seltorexant is in phase 3 clinical trials for treatment of major depressive disorder (MDD) and phase 2 trials for treatment of insomnia. It was also under investigation for the treatment of
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental anti-insomnia drug
original url:
https://en.wikipedia.org/wiki/Seltorexant
date created:
date modified:
2024-01-07T07:20:28Z
main entity:
{"identifier":"Q27273944","url":"https://www.wikidata.org/entity/Q27273944"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/54/MIN-202.svg","width":512,"height":227}
fields total:
13
integrity:
15